✦ LIBER ✦

Ado-trastuzumab emtansine approved for advanced breast cancer

✍ Scribed by Traynor, K.

Book ID: 120219240
Publisher: American Society of Health-System Pharmacists
Year: 2013
Tongue: English
Weight: 90 KB
Volume: 70
Category: Article
ISSN: 1079-2082
DOI: 10.2146/news130023

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Trastuzumab Emtansine for HER2-Positive

Trastuzumab Emtansine for HER2-Positive Advanced Breast Cancer

✍ Verma, Sunil; Miles, David; Gianni, Luca; Krop, Ian E.; Welslau, Manfred; Baselg 📂 Article 📅 2012 🏛 Massachusetts Medical Society 🌐 English ⚖ 365 KB

Trastuzumab emtansine (T-DM1) for HER2-p

Trastuzumab emtansine (T-DM1) for HER2-positive breast cancer

✍ Boyraz, Baris; Sendur, Mehmet A.N.; Aksoy, Sercan; Babacan, Taner; Roach, Emir C 📂 Article 📅 2013 🏛 Informa plc 🌐 English ⚖ 609 KB

Ado-trastuzumab emtansine (T-DM1): a nov

Ado-trastuzumab emtansine (T-DM1): a novel antibody-drug conjugate for the treatment of HER2-positive metastatic breast cancer

✍ Baron, J. M.; Boster, B. L.; Barnett, C. M. 📂 Article 📅 2014 🏛 SAGE Publications 🌐 English ⚖ 165 KB

Trastuzumab: new weapon against breast c

Trastuzumab: new weapon against breast cancer approved

📂 Article 📅 1998 🏛 Adis International Limited (now part of Wolters Kl ⚖ 136 KB

Trastuzumab Emtansine (T-DM1): A Novel A

Trastuzumab Emtansine (T-DM1): A Novel Agent for Targeting HER2+ Breast Cancer

✍ Howard A. Burris III; Jay Tibbitts; Scott N. Holden; Mark X. Sliwkowski; Gail D. 📂 Article 📅 2011 🏛 CIG Media Group, LP. 🌐 English ⚖ 851 KB

Trastuzumab provisionally approved for e

Trastuzumab provisionally approved for early breast cancer in NZ

📂 Article 📅 2006 🏛 Adis International Limited (now part of Wolters Kl ⚖ 133 KB